⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

May 1, 1996Critical Care Medicine

Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock

Konrad Reinhart Carola Wiegand-Lohnert Friedrich Grimminger Martin Kaul Stuart Withington David Treacher J. Eckart Sheila M. Willatts Carmen Bouza Dietmar Krausch Felix Stockenhuber Jurgen Eiselstein Lothar Daum J. Kempeni

View at Publisher

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Discussion

Loading...

Member takes

Cite This Study

Reinhart et al. (1996) studied this question.

synapsesocial.com/papers/6a09812387ad1657d25165e5 https://doi.org/10.1097/00003246-199605000-00003

View at Publisher

Ask AI

Bookmark

Share

Keep reading

More from Critical Care Medicine

More from Friedrich Schiller University Jena